Because VEGF-A neutralizing antibody and multi-tyrosine kinase VEGFR inhibitor have been widely used in the treatment of cancer for suppressing angiogenesis, VEGFR1 inhibition would be a useful tool for regulation of endometriosis-associated angiogenesis in reproductive aged women. Here, FLT1 is linked to cancer.